12. Aiom-Airtum. I Numeri del Cancro in Italia. Edizione 2018. Disponibile online: https://www.aiom.it/wp-con-tent/uploads/2018/10/2018_NumeriCancro-operatori. pdf
13. Aiom-Airtum. I Numeri del Cancro in Italia. Edizione 2020. Disponibile online: https://www.aiom.it/wp-con- tent/uploads/2020/10/2020_Numeri_Cancro-operato-ri_web.pdf
14. F. S. Mennini, Gianluca Fabiano, G. Favato, P. Sciattella, P. Bonanni, C. Pinto, A. Marcellusi. Economic burden of HPV9-related diseases: a real-world cost analysis from Italy. The European Journal of Health Economics. March 2019
15. Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine 2012;30(Suppl 5):F12-23.
16. International Agency for Research on Cancer, World Health Organization. Estimated age-standardized inci-dence rates (World) in 2020, worldwide, both sexes, all ages. Disponibile online: https://gco.iarc.fr/ (Ultimo ac-cesso: 2 luglio 2021)
17. International Agency for Research on Cancer, World Health Organization. Incidence, prevalence and mortal-ity rates (World) in 2020. Disponibile online: https://gco. iarc.fr/ (Ultimo accesso: 2 luglio 2021)
18. World Health Organization. Global strategy to acceler-ate the elimination of cervical cancer as a public health problem.2020. Disponibile online: https://www.who.int/ publications/i/item/9789240014107
19. World Health Organization. “WHO releases new esti-mates of the global burden of cervical cancer associ-ated with HIV”. Disponibile online: https://www.who.int/ news/item/16-11-2020-who-releases-new-estimates- of-the-global-burden-of-cervical-cancer-associated-with-hiv
20. Department of Health and Ageing. Immunise Austra-lia program: human papillomavirus (HPV). February 14, 2013.Disponibile online: http://www.health.gov.au/ internet/immunise/publishing.nsf/ Content/immu-nise-hpv
21. Tabrizi SN, Brotherton JM, Kaldor JM, et al. Fall in hu-man papillomavirus prevalence following a national vaccination program. J Infect Dis 2012; 206: 1645–51; 22. Gertig DM, Brotherton JM, Budd AC, Drennan K,
Chap-pell G, Saville AM. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study. BMC Med 2013; 11: 227;
23. Brotherton JM, Malloy M, Budd AC, Saville M, Drennan KT, Gertig DM. Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: observational cohort of young women in Australia. Papillomavirus Re-search 2015; 1: 59–72
24. Office of the Prime Minister of Australia. A new vac-cine to strengthen the health of young Australians. Oct 8, 2017. Disponibile online: http://parlinfo.aph.gov. au/ parlInfo/search/display/display.w3p; query=Id%3A%-22media%2F pressrel%2F5562151%22
25. Brotherton JML, Tabrizi SN, Phillips S, et al. Looking beyond human papillomavirus (HPV) genotype 16 and 18: defining HPV genotype distribution in cervical can-cers in Australia prior to vaccination. Int J Cancer 2017; 141: 1576–84
26. Simms KT, Laprise JF, Smith MA, et al. Cost-effective-ness of the next generation nonavalent human pap-illomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis. Lancet Public Health 2016; 1: e66– 75
27. Simms KT, Smith MA, Lew JB, Kitchener HC, Castle PE, Canfell K. Will cervical screening remain cost-ef-fective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries. Int J Cancer 2016; 139: 2771–80;
28. Pedersen K, Burger EA, Nygard M, Kristiansen IS, Kim JJ. Adapting cervical cancer screening for women vac-cinated against human papillomavirus infections: the value of stratifying guidelines. Eur J Cancer 2018; 91: 68–75
29. Cancer Council Australia Cervical Cancer Screening Guidelines Working Party. National cervical screening program: guidelines for the management of screen-de-tected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding. Dec 4, 2017. Disponibile online: http://wiki.cancer.org.au/aus-tralia/Guidelines:Cervical_ cancer/Screening
30. NHMRC Centre of Research Excellence in Cervical Cancer Control. Cervical Cancer Elimination Progress Report: Australia’s progress towards the elimination of cervical cancer as a public health problem. 2021. Dis-ponibile online: https://www.cervicalcancercontrol.org. au/wp-content/uploads/2021/03/2021-C4-CRE-Elim-Report.pdf
31. Canadian Network on HPV Prevention. Canada’s role in Accelerating Global Elimination of Cervical Cancer. July 2019
32. Asempah, Eric. “Cervical Cancer Prevalence in sub-Sa-haran Africa and HPV Vaccination Policy: A Public Health Grand Challenge?.”. J Cancer Immunol. 2021. Vol 3 Issue 2:87-97
33. Ngcobo, Ntombenle, et al. “Reflection: burden of cer-vical cancer in Sub-Saharan Africa and progress with HPV vaccination.” Current Opinion in Immunology 71 (2021): 21-26.
34. European Commission. Communication from the Com-mission to the European Parliament and the Council. Europe’s Beating Cancer Plan. Feb 2021. Disponibile online: https://ec.europa.eu/health/non_communica-ble_diseases/cancer_en.
35. ECCO, Eliminating HPV-Caused Cancers & Diseases in Europe, 2019 Dec https://www.ecco-org.eu/Global/ News/Latest-News/2019/12/NEWS-Headlines-from-the-ECCO-event-on-HPV-caused-cancer-elimination 36. Members of the Mission Board for Cancer; Pedro Pita
Barros, Regina Beets-Tan, Christine Chomienne (co-Chair), Serban Ghiorghiu, Fiona Godfrey, Ruth Laden-stein, Marcis Leja, Tomi Mäkelä, Andres Metspalu, Mar-tine Piccart, Walter Ricciardi (Chair), Konrad Rydzynski,
Anne Lise Ryel, Bettina Ryll, Elisabete Weiderpass. Conquering cancer: mission possible. Report of the Mission Board for Cancer. September 2020. Disponibile online: https://ec.europa.eu/info/sites/default/files/ research_and_innovation/funding/documents/ec_rtd_ mission-board-report-cancer.pdf
37. Ministero della Salute. Piano Nazionale Prevenzione Vaccinale PNPV 2017-2019. Disponibile online: https:// www.salute.gov.it/imgs/C_17_pubblicazioni_2571_alle-gato.pdf
38. Ministero della Salute. Piano Nazionale di Prevenzione (PNP) 2014-2018. Disponibile online: https://www.sa-lute.gov.it/imgs/C_17_pubblicazioni_2285_allegato.pdf 39. Osservatorio Nazionale Screening. Disponibile al sito:
https://www.osservatorionazionalescreening.it/con-tent/lo-screening-cervicale.
40. Ministero della Salute. Piano Nazionale della Preven-zione 2020-2025. Disponibile online: http://www.salute. gov.it/imgs/C_17_notizie_5029_0_file.pdf
41. Paola Mantellini, Patrizia Falini, Giuseppe Gorini, Fran-cesca Battisti, Priscilla Sassoli de Bianchi, Paola Arma-roli, Jessica Battagello, Paolo Giorgi Rossi, Pamela Gi-ubilato, Carlo Senore, Leonardo Ventura, Manuel Zorzi, Martina Rossi e Marco Zappa. Rapporto sui ritardi ac-cumulati dai programmi di screening Italiani in seguito alla pandemia da Covid 19. Terzo Rapporto aggiornato al 31 Dicembre 2020. Disponibile online: https://www. osservatorionazionalescreening.it/sites/default/files/ allegati/Rapporto%20ripartenza-12_20.pdf
42. Istituto Superiore di sanità. La pandemia COVID-19 e la riduzione o sospensione delle attività vaccinali a livello
globale. Disponibile online: https://www.epicentro.iss. it/vaccini/covid-19-riduzione-attivita-vaccinale (Ultimo accesso: 2 luglio 2021)
43. Ministero della Salute. Vaccinazione contro il papilloma virus (HPV) - Coperture vaccinali. Disponibile online: https://www.salute.gov.it/imgs/C_17_tavole_27_1_2_ file.pdf (Ultimo accesso 2 luglio 2021)
44. A. Acampora, A. Grossi, A. Barbara, A. Causio, G.E. Ca-labrò, A. Cicchetti, C. de Waure. Strategies to achieve HPV-related disease control in Italy: results from an integrative approach. Epidemiology Biostatistics and Public Health - 2019, Volume 16, Number 3)
45. Anna Acampora, Adriano Grossi, Andrea Barbara, Vit-toria Colamesta, Francesco Andrea Causio, Giovanna Elisa Calabrò, Stefania Boccia, Chiara de Waure. In-creasing HPV Vaccination Uptake among Adolescents: A Systematic Review. Int J Environ Res Public Health. 2020 Oct 30;17(21):7997.
46. Michele Basile, Paolo Bonanni, Giovanna Elisa Calabrò, Elettra Carini, Americo Cicchetti, Michele Conversano, Rosa De Vincenzo, Carlo Favaretti, Alessandro Ghelardi, Silvio Tafuri. Report di approfondimento e valutazione, con metodologia HTA (Health Technology Assessment), della vaccinazione anti-HPV nelle donne trattate per le-sioni HPV-correlate. QIJPH - 2019, Volume 8, Number 7 47. Sanchia Aranda, Seth Berkley, Sally Cowal, Mark Dybul,
Tim Evans, Katja Iversen, Matshidiso Moeti, Babatunde Osotimehin, Stefan Peterson, Peter Piot, Chittaranjan N. Purandare, Michel Sidibé, Ted Trimble, Vivien Davis Tsu. Ending cervical cancer: A call to action. Int J Gyne-col Obstet 2017; 138 (Suppl. 1): 4–6).